| 查看: 550 | 回复: 0 | |||
[交流]
尘螨过敏的过敏性鼻炎患者舌下脱敏起效时间：随机双盲安慰剂对照试验
|
|
Objectives/Hypothesis: To investigate how quickly an allergic rhinitis (AR) patients’ symptoms will improve with sublingual immunotherapy (SLIT). Study Design: Double-blind placebo study. Methods: This is a multicenter, randomized, double-blind, placebo-controlled study of SLIT used to treat house dust mite-induced AR. A total of 120 AR patients, aged 4 to 60 years, were treated for 6 months and randomized into two groups:1) SLIT with Dermatophagoides pteronyssinus (D.p.) and Dermatophagoides farina (D.f.) extract (n 5 60) ; and 2) matched placebo controls (n 5 60). Symptom, medications received, and a visual analog scale score were recorded during the whole study. Serum-specific IgE and IgG4 to D. p. and D. f. were assessed before and after the treatment. Results: Eighty-five patients (70.8%) completed the study. Twelve patients (20%) chose to withdraw from the SLIT group, but none because of serious adverse effects. The total symptom and visual analog scores VAS in the SLIT group decreased significantly when compared to the placebo controls (P <0.05) after week 14, as well as for the significant (P <0.05) improvement of all individual AR symptoms in the SLIT group (e.g., sneezing, nasal discharge, itching, and nasal obstruction) after week 22. There was a significant (P <0.05) increase of IgG4 to both D.f. and D.p. in the SLIT, but not in the placebo group after treatment. Conclusion: SLIT with a mixture of D.f. and D.p. extract is an effective and safe treatment for patients with house dust mite-induced AR. Its onset of action can be observed as early as 14 weeks after treatment. |
回复此楼» 猜你喜欢
最近网站变化
已经有8人回复
-
应该是依托单位先拿到结果吧
已经有2人回复
-
放射医学论文润色/翻译怎么收费?
已经有52人回复
-
d点击grid/output/Save GPF后，
已经有0人回复
-
医学口青基，明天开始会评，祈福~
已经有41人回复
-
中国医科大学医学技术专硕（105800）接收调剂 生物医学工程方向
已经有0人回复